8-K/A XBRL

CURRENT REPORT

Company: ABVC BIOPHARMA, INC.
Filed: May 6, 2025
Period of Report: April 30, 2025
Accession Number: 0001213900-25-040194

View Document ↗ View on SEC.gov ↗